Publications by authors named "Yu Nagayoshi"

Claim this Profile
R
Rituximab as an Effective Treatment for New-onset Evans Syndrome and Systemic Lupus Erythematosus with Lupus Nephritis.
Koki Matsushita, Yu Nagayoshi, Ryuichi Yoshii, Tomohumi Nakamura, Kengo Kajiwara

Intern Med· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A case of acute abdomen caused by visceral disseminated varicella-zoster virus infection causes diagnostic challenges during the course of systemic lupus erythematosus.
Koki Matsushita, Yu Nagayoshi, Ryosuke Yamamura, Keishi Nakamura, Yutaka Kakizoe

IDCases· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bacteria-specific modified nucleoside is released and elevated in urine of patients with bacterial infections.
Ryosuke Yamamura, Yu Nagayoshi, Kayo Nishiguchi, Hitomi Kaneko, Keiichi Yamamoto

mBio· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TRMT10A dysfunction perturbs codon translation of initiator methionine and glutamine and impairs brain functions in mice.
Roland Tresky, Yuta Miyamoto, Yu Nagayoshi, Yasushi Yabuki, Kimi Araki

Nucleic Acids Res· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Serine Protease Inhibitor, Camostat Mesilate, Suppresses Urinary Plasmin Activity and Alleviates Hypertension and Podocyte Injury in Dahl Salt-Sensitive Rats.
Yasunobu Iwata, Qinyuan Deng, Yutaka Kakizoe, Terumasa Nakagawa, Yoshikazu Miyasato, Yu Nagayoshi

Int J Mol Sci· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The serine protease plasmin plays detrimental roles in epithelial sodium channel activation and podocyte injury in Dahl salt-sensitive rats.
Qinyuan Deng, Yutaka Kakizoe, Yasunobu Iwata, Terumasa Nakagawa, Yoshikazu Miyasato, Yu Nagayoshi

Hypertens Res· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Camostat mesilate, a serine protease inhibitor, exerts aquaretic effects and decreases urinary exosomal AQP2 levels.
Yutaka Kakizoe, Terumasa Nakagawa, Yasunobu Iwata, Qinyuan Deng, Masataka Adachi, Yu Nagayoshi

J Pharmacol Sci· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
tA and mstA Modified Nucleosides in Serum and Urine as Strong Candidate Biomarkers of COVID-19 Infection and Severity.
Yu Nagayoshi, Kayo Nishiguchi, Ryosuke Yamamura, Takeshi Chujo, Hiroyuki Oshiumi

Biomolecules· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of continuous erythropoietin receptor activator for end-stage renal disease patients with renal anemia before and after peritoneal dialysis initiation.
Daisuke Fujimoto, Masataka Adachi, Yoshikazu Miyasato, Yusuke Hata, Hideki Inoue, Yu Nagayoshi

Clin Exp Nephrol· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Autosomal dominant Alport syndrome due to a COL4A4 mutation with an additional ESPN variant detected by whole-exome analysis.
Yuichiro Izumi, Ami Hamaguchi, Rei Miura, Terumasa Nakagawa, Miyuki Nakagawa, Yu Nagayoshi

CEN Case Rep· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis